"MaRS Innovation (MI), The Hospital for Sick Children (SickKids) and NovoTek Therapeutics Inc. (NovoTek, Beijing/China) have announced a strategic partnership to co-develop a therapeutic cream aimed at reducing scar formation post surgery."
$1 million in seed money to back one of last year's most exciting medical breakthroughs, turning simple skin cells into stem cells.
A lab run by the Hospital for Sick Children and the University of Toronto in the MaRS (Medical and Related Sciences) complex on College St. has developed the expertise to grow the cells in quantity and is ready to roll.
The goal is to make cells that can replace tissue damaged by disease or accidents, with Sick Kids researchers particularly interested in cystic fibrosis and autism, a government source said.